• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[体内31P心脏磁共振波谱分析:方法及首次临床结果]

[In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results].

作者信息

Krahe T, Schindler R, Neubauer S, Hillenbrand H, Lackner K, Boesiger P, McKinnon G, Landwehr P, Ertl G

机构信息

Institut für Röntgendiagnostik, Universität Würzburg.

出版信息

Rofo. 1991 Dec;155(6):506-12. doi: 10.1055/s-2008-1033307.

DOI:10.1055/s-2008-1033307
PMID:1764590
Abstract

31P-magnetic resonance (MR) spectra of the heart can be obtained from well-defined myocardial regions by combined MR imaging and variable selected volumes for spectroscopy. 31P-spectra of 33 volunteers and of 43 patients with dilated and hypertrophic cardiomyopathy and with coronary artery disease were quantified using a curve-fitting routine. To optimize our technique, we recorded unsaturated and partially saturated spectra in several volunteers. Relative peak areas and signal-to-noise ratios showed significant changes with varying pulse repetition times. Saturation factors were applied to correct spectra from volunteers and patients for the effects of partial saturation. Under resting conditions, peak areas of volunteers and patients from the various groups were statistically indistinct.

摘要

通过磁共振成像(MR)与用于光谱分析的可变选定容积相结合,可从明确界定的心肌区域获取心脏的31P磁共振(MR)光谱。使用曲线拟合程序对33名志愿者以及43名患有扩张型和肥厚型心肌病及冠状动脉疾病的患者的31P光谱进行了定量分析。为优化我们的技术,我们在数名志愿者身上记录了不饱和及部分饱和光谱。相对峰面积和信噪比随脉冲重复时间的变化呈现出显著改变。应用饱和因子对志愿者和患者的光谱进行校正,以消除部分饱和的影响。在静息状态下,各分组中志愿者和患者的峰面积在统计学上无明显差异。

相似文献

1
[In vivo 31P-cardiac magnetic resonance spectroscopy: methods and the first clinical results].[体内31P心脏磁共振波谱分析:方法及首次临床结果]
Rofo. 1991 Dec;155(6):506-12. doi: 10.1055/s-2008-1033307.
2
[In-vivo 31P-NMR-spectroscopy in patients with dilated cardiomyopathy].[扩张型心肌病患者的体内31P核磁共振波谱分析]
Rofo. 1992 Nov;157(5):458-65. doi: 10.1055/s-2008-1033042.
3
(31)P magnetic resonance spectroscopy to measure in vivo cardiac energetics in normal myocardium and hypertrophic cardiomyopathy: Experiences at 3T.(31)P 磁共振波谱测量正常心肌和肥厚型心肌病的活体心脏能量学:3T 的经验。
Eur J Radiol. 2010 Feb;73(2):255-9. doi: 10.1016/j.ejrad.2008.10.018. Epub 2008 Dec 3.
4
[The quantification of energy-rich phosphates in healthy and damaged heart muscle by SLOOP 31P-MR spectroscopy. Spatial localization with optimal pointspread function].[通过SLOOP 31P磁共振波谱法对健康和受损心肌中富含能量的磷酸盐进行定量分析。采用最佳点扩散函数进行空间定位]
Rofo. 1999 Jul;171(1):65-8. doi: 10.1055/s-1999-9896.
5
Detection of phosphomonoester signals in proton-decoupled 31P NMR spectra of the myocardium of patients with myocardial hypertrophy.心肌肥厚患者心肌质子去耦31P NMR谱中磷酸单酯信号的检测。
J Magn Reson. 1998 Jul;133(1):232-5. doi: 10.1006/jmre.1998.1454.
6
[The direct measurement of the spin-grid-relaxation times of phosphorus metabolites in the human myocardium].[人体心肌中磷代谢物自旋晶格弛豫时间的直接测量]
Rofo. 1992 Nov;157(5):452-7. doi: 10.1055/s-2008-1033041.
7
[Localized 31 phosphorus NMR spectroscopy of the human heart--development of a measuring method and initial clinical application].[人体心脏的局部31磷核磁共振波谱学——测量方法的发展及初步临床应用]
Z Kardiol. 1991 Apr;80(4):266-71.
8
Cardiac MR spectroscopy in the new millennium.新千年的心脏磁共振波谱分析
Rays. 2001 Jan-Mar;26(1):93-107.
9
[Evaluation of myocardial energy metabolism by 31 P-magnetic resonance spectroscopy in patients with hypertrophic cardiomyopathy versus healthy individuals].[肥厚型心肌病患者与健康个体的31P磁共振波谱法心肌能量代谢评估]
Vestn Rentgenol Radiol. 2012 Nov-Dec(6):8-12.
10
[31P-cardio-MR-spectroscopy in myocardial insufficiency].
Rofo. 1993 Jul;159(1):64-70. doi: 10.1055/s-2008-1032723.

引用本文的文献

1
31P-MR spectroscopic imaging in hypertensive heart disease.高血压性心脏病中的磷-31磁共振波谱成像
Eur Radiol. 2006 Aug;16(8):1796-802. doi: 10.1007/s00330-006-0170-0. Epub 2006 Mar 2.